Stephanie F. Ling

Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Biologic and targeted synthetic DMARD safety in inflammatory arthritis: British Society for Rheumatology guideline scope.

Biologic and targeted synthetic DMARD safety in inflammatory arthritis: British Society for Rheumatology guideline scope.

Journal: Rheumatology advances in practice

Published: June 26, 2025

Pre-treatment GlycA measurement provides no additional predictive utility beyond routine clinical measures in patients with rheumatoid arthritis.

Pre-treatment GlycA measurement provides no additional predictive utility beyond routine clinical measures in patients with rheumatoid arthritis.

Journal: Rheumatology (Oxford, England)

Published: March 18, 2025

Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis.

Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis.

Journal: Pharmaceutics

Published: April 17, 2024

A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measures.

A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measures.

Journal: Rheumatology (Oxford, England)

Published: January 08, 2023

Vitamin D prescribing practices among clinical practitioners during the COVID-19 pandemic.

Vitamin D prescribing practices among clinical practitioners during the COVID-19 pandemic.

Journal: Health science reports

Published: November 22, 2021

Vitamin D Deficiency Is Associated With Higher Hospitalization Risk From COVID-19: A Retrospective Case-control Study.

Vitamin D Deficiency Is Associated With Higher Hospitalization Risk From COVID-19: A Retrospective Case-control Study.

Journal: The Journal of clinical endocrinology and metabolism

Published: April 02, 2021

High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study.

High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study.

Journal: Nutrients

Published: November 15, 2020

Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics.

Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics.

Journal: Scientific reports

Published: November 10, 2020

Pharmacogenetics of methotrexate response in rheumatoid arthritis: an update.

Pharmacogenetics of methotrexate response in rheumatoid arthritis: an update.

Journal: Pharmacogenomics

Published: December 19, 2019

Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients.

Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients.

Journal: The pharmacogenomics journal

Published: July 26, 2019

Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis.

Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis.

Journal: Rheumatology (Oxford, England)

Published: July 31, 2018

Isolated DLco/VA reduction in systemic sclerosis patients: a new patient subset?

Isolated DLco/VA reduction in systemic sclerosis patients: a new patient subset?

Journal: Clinical rheumatology

Published: July 23, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026